Trehalose: A Promising Therapeutic Agent for Diverse Pathological Conditions

2026/03/06 by Mahboobeh Ghasemzadeh Rahbardar, Prashant Kesharwani, Amirhossein Sahebkar · 1 voice
Agricultural and Biological Sciences · Biochemistry, Genetics and Molecular Biology · Medicine · #Autophagy in Disease and Therapy #Fungal and yeast genetics research #Tardigrade Biology and Ecology

paper · doi:10.1007/s11596-026-00174-z

crossref issued 2026/03/06 · crossref published 2026/03/06 · crossref published-online 2026/03/06 · openalex publication_date 2026/03/06 · crossref created 2026/03/06 · openalex created_date 2026/03/07 · crossref published-print 2026/04/01 · crossref deposited 2026/04/28 · crossref indexed 2026/04/29 · openalex updated_date 2026/08/03

Citations

• Trehalose Inhibits Human Immunodeficiency Virus Type 1 Infection in Primary Human Macrophages and CD4 + T Lymphocytes through Two Distinct Mechanisms
• Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021

Discussions

• This review emphasizes the #therapeutic potential of #Trehalose in #DiseaseManagement and its capacity to inform the development of innovative treatment strategies. #medsky To read: doi.org/10.1007/ [bsky, 0 points, 0 comments]